Phase I Single-dose Escalation Clinical Trial of Salvianolic Acid A Tablets

NCT03791125 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Neuropathy of Diabetes

Interventions

DRUG: Salvianolic Acid A
DRUG: Placebo Oral Tablet

Sponsor

Peking University First Hospital

Collaborators

[object Object]
[object Object]